Log in to save to my catalogue

Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less select...

Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less select...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6498410

Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist

About this item

Full title

Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist

Publisher

United States: John Wiley and Sons Inc

Journal title

Pharmacology research & perspectives, 2019-06, Vol.7 (3), p.e00471-n/a

Language

English

Formats

Publication information

Publisher

United States: John Wiley and Sons Inc

More information

Scope and Contents

Contents

Metabotropic glutamate receptors (mGluRs) are class C G protein coupled receptors with widespread expression in the central nervous system. There are eight mGluRs in the mammalian genome. Research on mGluRs relies on the availability of selective compounds. While many selective allosteric compounds have been described, selectivity of orthosteric ag...

Alternative Titles

Full title

Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6498410

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6498410

Other Identifiers

ISSN

2052-1707

E-ISSN

2052-1707

DOI

10.1002/prp2.471

How to access this item